Mono Rosemary - Oral English
Mono Rosemary - Oral English
This monograph is intended to serve as a guide to industry for the preparation of Product Licence
Applications (PLAs) and labels for natural health product market authorization. It is not intended
to be a comprehensive review of the medicinal ingredient.
Notes
Text in parentheses is additional optional information which can be included on the PLA and
product label at the applicant’s discretion.
The solidus (/) indicates that the terms and/or statements are synonymous. Either term or
statement may be selected by the applicant.
References: Proper name: USDA 2018; Common name: McGuffin et al. 2000; Source material: Blumenthal
et al. 2000.
Route of administration
Dosage form(s)
This monograph excludes foods or food-like dosage forms as indicated in the Compendium of
Monographs Guidance Document.
Acceptable dosage forms for the age category listed in this monograph and specified route of
administration are indicated in the Compendium of Monographs Guidance Document.
Use(s) or Purpose(s)
(Traditionally) used in Herbal Medicine to help ease (gastric) headaches and relieve flatulent
indigestion (carminative) (Barnes et al. 2007; Bradley 2006; Mills and Bone 2005; ESCOP 2003;
Hoffmann 2003; Blumenthal et al. 2000; Tilgner 1999; Grieve 1971).
Note
Claims for traditional use must include the term “Herbal Medicine”, “Traditional Chinese
Medicine”, or “Ayurveda”.
Dose(s)
Subpopulation(s)
Quantity(ies)
0.6 - 12 grams of dried leaf, per day (Barnes et al. 2007; Mills and Bone 2005; ESCOP 2003;
Hoffmann 2003; Blumenthal et al. 2000; BHP 1983).
2 - 12 grams of dried leaf, per day (Mills and Bone 2005; ESCOP 2003; Blumenthal et al. 2000;
BHP 1983).
No statement required.
No statement required.
Risk information
Contraindication(s)
Do not use this product if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007;
Blumenthal et al. 2000; McGuffin et al. 1997)
No statement required.
Non-medicinal ingredients
Must be chosen from the current Natural Health Product Ingredient Database (NHPID) and must
meet the limitations outlined in the database.
Storage conditions
No statement required.
Specifications
The finished product specifications must be established in accordance with the requirements
described in the Natural and Non-prescription Health Products Directorate (NNHPD) Quality
of Natural Health Products Guide.
The medicinal ingredient must comply with the requirements outlined in the NHPID.
References cited
Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The
Pharmaceutical Press; 2007.
Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic
Medical Publications; 2010.
ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products,
2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Grieve M. A Modern Herbal, Volume 2. New York (NY): Dover Publications; 1971 [Reprint of
1931 Harcourt, Brace & Company publication].
McGuffin M, Kartesz JT, Leung AY, Tucker AO, editors. Herbs of Commerce, 2nd edition.
Silver Spring (MD): American Herbal Products Association; 2000.
Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill
Livingstone; 2005.
Tilgner S. Herbal Medicine from the Heart of the Earth. Creswell (OR): Wise Acre Press; 1999.
USDA 2018: United States Department of Agriculture, Agricultural Research Service, National
Genetic Resources Program. Germplasm Resources Information Network (GRIN). Rosmarinus
officinalis L. National Germplasm Resources Laboratory, Beltsville (MD). [Accessed 2018
October 1]. Available from: https://npgsweb.ars-
grin.gov/gringlobal/taxonomydetail.aspx?id=32207
Williamson EM, Evans FJ, Wren RC. Potter's New Cyclopaedia of Botanical Drugs and
Preparations. Saffron Walden (UK): C.W. Daniel Company Limited; 1988.